Evidence map›Paper›PMID 23771687›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2013

Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias.

Anthony W Herren, Donald M Bers, Eleonora Grandi

Abstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Ion channel trafficking implications in heart failure.Frontiers in cardiovascular medicine · 2024
    Review
  5. Challenges in Brugada Syndrome Stratification: InvestigatingInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  9. Article
  10. Alterations of the Sialylation Machinery in Brugada Syndrome.International journal of molecular sciences · 2022
    Article
  11. Article
  12. Review
  13. American journal of physiology. Heart and circulatory physiology · 2022
    Article
  14. Absolute Quantification of Nav1.5 Expression by Targeted Mass Spectrometry.International journal of molecular sciences · 2022
    Article
  15. Review
  16. Review
  17. Frontiers in pharmacology · 2022
    Article
  18. Article
  19. Autonomic modulation of ventricular electrical activity: recent developments and clinical implications.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anthony W HerrenDepartment of Pharmacology, University of California Davis, Davis, California.
Donald M Bers
Eleonora Grandi
University of California, Davis · US

Funding

Program AdministrationP01HL080101 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2006 to 2015
$23.4M
IONIC CONTROL OF CARDIAC MUSCLE CONTRACTION: EC COUPLINGR37HL030077 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M · 2005 to 2014
$3.9M
Multi-scale Systems Model of Murine Heart FailureR01HL105242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BERS, DONALD M, MCCULLOCH, ANDREW D. · 2012 to 2016
$3.5M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
NHLBI NIH HHS P01 HL080101NHLBI NIH HHS P01-HL-080101NHLBI NIH HHS R01 HL105242NHLBI NIH HHS R01-HL-105242NHLBI NIH HHS R37 HL030077NIGMS NIH HHS T32 GM099608NIGMS NIH HHS T32-GM-099608
6 · The paper itself

Abstract

The voltage-gated Na channel isoform 1.5 (NaV1.5) is the pore forming α-subunit of the voltage-gated cardiac Na channel, which is responsible for the initiation and propagation of cardiac action potentials. Mutations in the SCN5A gene encoding NaV1.5 have been linked to changes in the Na current leading to a variety of arrhythmogenic phenotypes, and alterations in the NaV1.5 expression level, Na current density, and/or gating have been observed in acquired cardiac disorders, including heart failure. The precise mechanisms underlying these abnormalities have not been fully elucidated. However, several recent studies have made it clear that NaV1.5 forms a macromolecular complex with a number of proteins that modulate its expression levels, localization, and gating and is the target of extensive post-translational modifications, which may also influence all these properties. We review here the molecular aspects of cardiac Na channel regulation and their functional consequences. In particular, we focus on the molecular and functional aspects of Na channel phosphorylation by the Ca/calmodulin-dependent protein kinase II, which is hyperactive in heart failure and has been causally linked to cardiac arrhythmia. Understanding the mechanisms of altered NaV1.5 expression and function is crucial for gaining insight into arrhythmogenesis and developing novel therapeutic strategies.

Indexed as

Protein Processing, Post-TranslationalAction PotentialsAnimalsArrhythmias, CardiacCalcium-Calmodulin-Dependent Protein Kinase Type 2Genetic Predisposition to DiseaseHumansIon Channel GatingKineticsMutationMyocardiumNAV1.5 Voltage-Gated Sodium ChannelPhenotypePhosphorylationPrognosisSodiumCalcium-Calmodulin-Dependent Protein Kinase Type 2NAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanSodiumarrhythmiaCaMKIIheart failureNa channelphosphorylation

Identifiers

PMID23771687
PMCPMC3891248
OpenAlexW2024695712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.